Twelve nationally and internationally renowned architecture firms have participated at the private study. The presented projects have been preevaluated by an expert jury and the leading exponents of the company, the city and the canton then have chosen the winner. The Swiss architects Gigon/Guyer with their project LICHTSPIEL (moving picture) have won the competition.
In September 2008 the Wurth-Group announced its investment in Rorschach. In February 2009 the eligible voters of the city of Rorschach have confirmed with a huge majority that the land can be sold to Wurth. The company plans to establish a representative administrative building with congress and trainings facilities. The project provides 250 to 500 new workplaces which will be established over the next 10 to 15 years.
The following architecture firms have participated:
- Baumschlager-Eberle Architectural Devices AG, St. Gallen/Lochau
- David Chipperfield Architects Ltd., London/Berlin
- Dietrich/Untertrifaller ZT GmbH, St. Gallen/Bregenz
- Annette Gigon / Mike Guyer, Zurich
- Grazioli/Krischanitz GmbH, Zurich/Berlin/Wien
- D. Jüngling und A. Hagmann Architekten, Chur
- KCAP Architects & Planners, Zurich
- Architect Daniel Libeskind AG, Zurich/New York
- Carlos Martinez Architects AG, Widnau and bb architecture GmbH, Rorschach
- Meili, Peter Architekten AG, Zürich
- mdm Architecst BDA, Stuttgart
- Tilla Theus and Partner AG, Zurich
]]>The world leader in the global trade in fastening and assembly technology Wurth builds a new training and services centre with at least 250 employees.
In Rorschach in the Canton of St.Gallen they found the ideal location on the shore of Lake Constance and near the business airport St.Gallen-Altenrhein.
]]>The Vifor-business runs: Just two years ago a 50-Million-Swiss-Francs-extention has been finalised. On the world market Vifor is considered as a leader in iron replacement products. And there a new plans already. For the large scale production of a new drug which goes on testing-line in 2009, a new factory is built. Vifor, member of the Galinica-group, will invest in a grand scale: For the development of drugs as well as for the infrastructure of the production unit an investment of 100 Million Swiss Francs was concluded.
]]>